A detailed history of Exchange Traded Concepts, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 6,797 shares of RVMD stock, worth $300,223. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,797
Previous 8,910 23.71%
Holding current value
$300,223
Previous $287,000 8.36%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$30.14 - $40.68 $63,685 - $85,956
-2,113 Reduced 23.71%
6,797 $263,000
Q1 2024

Apr 15, 2024

SELL
$26.56 - $33.55 $63,000 - $79,580
-2,372 Reduced 21.02%
8,910 $287,000
Q4 2023

Jan 05, 2024

BUY
$18.35 - $34.12 $146,561 - $272,516
7,987 Added 242.4%
11,282 $323,000
Q3 2023

Oct 18, 2023

SELL
$25.17 - $35.05 $56,934 - $79,283
-2,262 Reduced 40.71%
3,295 $91,000
Q2 2023

Jul 20, 2023

BUY
$20.28 - $27.0 $112,695 - $150,039
5,557 New
5,557 $148,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.87B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.